No products in the cart.
CA 19-9 (Pancreatic Cancer)
Roll over image to zoom in
75,000UGX
This test measures the amount of a protein called cancer antigen 19-9 (CA 19-9) in the blood helping to monitor the progress of pancreatic cancer treatment.
Blood.
No specific patient preparation protocol required. Inform the doctor if you are on any medications, have any allergies or underlying medical conditions before this test.
Cancer antigen 19-9 (CA 19-9) is a protein that exists on the surface of certain cancer cells. CA 19-9 does not cause cancer; rather, it is shed by the tumor cells and can be detected by laboratory tests in blood and sometimes other body fluids. CA 19-9 is elevated in about 70% to 95% of people with advanced pancreatic cancer. However, CA 19-9 may also be elevated in other cancers, conditions, and diseases such as: gallbladder and bile duct cancers (cholangiocarcinoma), colorectal cancer, gastric cancers, ovarian cancer, lung cancer, liver cancer, bile duct obstruction (e.g., gallstones), pancreatitis, cystic fibrosis, thyroid disease, and liver disease. Small amounts of CA 19-9 are present in the blood of healthy people. Since CA 19-9 is not specific for pancreatic cancer, it cannot be used by itself for screening or diagnosis.
